Croma Pharma expands globally

17 Sep 2020

Medical aesthetic product manufacturer Croma-Pharma GmbH has partnered with China National Biotec Group Company (CNBG) to enter the Chinese market to supply the country with its hyaluronic acid filler Princess VOLUME, as well as other products in the company’s portfolio.

On the partnership, Andreas Prinz, CCO and co-owner of Croma, said, "Croma incorporates more than 40 years of experience in viscoelastic products. Our fully automated production lines deliver eight million pre-filled injectables per year. With CNBG, we have found the perfect partner to merge our strengths and assets to successfully enter the fast-growing Chinese market. CNBG’s track-record and experience will heavily support Croma to sustainably prosper in Asia."

Xiangrong Li, vice-president of CNBG, said, “CNBG, via its affiliate Lanzhou, has been very successful for years with its botulinum toxin in China. Our search for suitable HA filler products has finally come to an end – Croma indeed is the perfect partner and best possible fit for us. Together we are committed to shape and conquer the Chinese market with all its immense growth potential.”


Log-in to post a comment